Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Biochim Biophys Acta. 2010 Feb 1;1801(5):559–566. doi: 10.1016/j.bbalip.2010.01.007

Fig. 7. HIV-protease inhibitor treatment decreases [14C]-palmitate uptake in C2C12 myotubes.

Fig. 7

C2C12 myotubes were treated for 18 h with HIV-PIs in combination (ATV/r, LPV/r, and DRV/r; 20/5 μmol/l, respectively) followed by a fatty acid load (200/100 μmol/l oleate/palmitate) for 3 h. Myotubes were harvested and assayed for [14C]-palmitate incorporation. Results are mean ± SEM (n = 3 in each group). *PI groups significantly different from Con (DMSO) group (p ≤ 0.05).